The U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for the Becton, Dickinson and Company (BD) Veritor At-Home COVID-19 Test, the agency said.
The BD Veritor At-Home COVID-19 Test is an over-the-counter (OTC) diagnostic antigen test that gives results in 15 minutes. The test can be used:
- As a single test for people with COVID-19 symptoms.
- As a serial test for people without COVID-19 symptoms, meaning the test must be done twice over three days.
The FDA reissued the EUA to authorize use of the BD Veritor At-Home COVID-19 Test as a single test without a prescription for people with COVID-19 symptoms. The test was already authorized for use as a serial test without a prescription by people with or without COVID-19 symptoms.